Medication Overuse Headache
Frequent use of analgesics, ergots, or triptans to treat acute headaches can lead to rebound or medication overuse headache. This FAQ reviews risk factors for medication overuse headache in adults and options for treatment and prevention.
|
Question |
Answer/Pertinent Information |
|
What is a medication overuse headache? |
Medication overuse headache is a secondary, drug-induced headache that can stem from any type of primary headache (e.g., migraine [most common], tension, cluster).1,2 Medication overuse headache occurs ≥15 days per month (even daily) because of regular overuse of acute headache medication for >3 months.1,2,12 |
|
Which acute headache treatments can cause medication overuse headache? |
Butalbital and opioids pose the highest risk.3,7 Triptans are becoming the most frequent cause due to widespread triptan use.2 They seem to cause medication overuse headaches with shorter duration of use and at lower doses than ergots.4 Acetaminophen and combination analgesics (especially with caffeine)maypose a higher risk than NSAIDs.3,4 Lasmiditan (Reyvow) may be a culprit, based on its mechanism of action.6 |
|
What are some other risk factors for medication overuse headache? |
Medication overuse headache is more common in
|
|
How do you identify patients with medication overuse headache? |
Watch for refill requests suggesting use of triptans, ergots, combination analgesics, or opioids for ≥10 days per month, or NSAIDs for ≥15 days/month.1,4,12 Patients with ergot or analgesic overuse more commonly report tension-type headaches, while triptan overuse headaches tend to be migraine-like.2 |
|
How can medication overuse headache be prevented?
|
Ensure appropriate use of acute headache medications1 (e.g., maximum triptan dose taken at the first sign of headache to increase efficacy).See our charts, Comparison of Triptans and Other Drugs for Acute Migraine (US) and Comparison of Triptans (Canada), for help with choice of agent and dosing. Avoid use of butalbital or opioids to treat headache.3 Recommend NSAIDs over acetaminophen.3 Advise patients to try to limit acute treatment to two headache days per week, on average.6
Educate patients that analgesics taken for other conditions (e.g., back pain) can contribute to medication overuse headache.1 Consider a prophylactic med if patients have frequent headaches (e.g., 4 migraine days/month),10 or are using analgesics at a frequency that puts them at risk of medication overuse headache.12 |
|
How is medication overuse headache treated? |
Treatment is not based on high-level evidence.1 Consider adding a prophylactic medication before, during, or after stopping the offending medication.1,4,6 Patients with medication overuse headache despite prophylactic treatment may need a dosage increase of the prophylactic treatment, a change in prophylactic treatment, or the addition of a second prophylactic agent.6
Consider reducing or stopping/tapering the offending medication.4 See details below. Consider switching to a different acute med.
|
|
How should the offending medication be stopped/tapered? |
Reduce use of acute medication to ≤2 days per week.1 Stopping the acute medication may worsen headache or cause nausea, vomiting, irritability, and sleep disruption.9 These symptoms may last for four weeks, but usually resolve in two to ten days.9 Tapering is not necessary for acetaminophen, NSAIDs, or triptans.12 Tapering butalbital or opioids may be needed to prevent withdrawal from these drugs. For help, see our chart, Common Oral Medications that May Need Tapering. Inpatient treatment may be needed for some patients (e.g., failure of outpatient taper, psychiatric comorbidities, significant medical conditions, seizure disorder, excessive use of butalbital or opioids).1 Consider adding medications to help the patient with withdrawal headache, nausea, and other symptoms during the transition (i.e., bridging therapy).1 Examples include (not supported by high-level data; doses are for adults):
|
Levels of Evidence
In accordance with our goal of providing Evidence-Based information, we are citing the LEVEL OF EVIDENCE for the clinical recommendations we publish.
|
Level |
Definition |
Study Quality |
|
A |
Good-quality patient-oriented evidence.* |
|
|
B |
Inconsistent or limited-quality patient-oriented evidence.* |
|
|
C |
Consensus; usual practice; expert opinion; disease-oriented evidence (e.g., physiologic or surrogate endpoints); case series for studies of diagnosis, treatment, prevention, or screening. |
|
*Outcomes that matter to patients (e.g., morbidity, mortality, symptom improvement, quality of life).
[Adapted from Ebell MH, Siwek J, Weiss BD, et al. Strength of Recommendation Taxonomy (SORT): a patient-centered approach to grading evidence in the medical literature. Am Fam Physician 2004;69:548-56. https://www.aafp.org/afp/2004/0201/p548.pdf.]
References
- Diener HC, Dodick D, Holle D, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol 2019;18:891-902.
- Silberstein SD. Headache management. In: Benzon HT, Rathmell JP, Wu CL, et al., Eds. Practical management of pain. 5th Philadelphia, PA: Elsevier, 2014:408-23.
- McNeil M. Headaches in adults in primary care: evaluation, diagnosis, and treatment. Med Clin North Am 2021;105:39-53.
- Alstahaug KB, Ofte HK, Kristoffersen ES. Preventing and treating medication overuse headache. Pain Rep 2017;2:e612. doi: 1097/PR9.0000000000000612.
- Caronna E, Gallardo VJ, Alpuente A, et al. Anti-CGRP monoclonal antibodies in chronic migraine with medication overuse: real-life effectiveness and predictors of response at 6 months. J Headache Pain 2021;22:120. doi: 1186/s10194-021-01328-1.
- Ailani J, Burch RC, Robbins MS, Board of Directors of the American Headache Society. The American Headache Society consensus statement: update on integrating new migraine treatments into clinical practice. Headache2021;61:1021-39.
- Vandebussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain 2018;19:50. doi: 1186/s10194-018-0875-x.
- Begasse de Dhaem O. When your migraine medicine does more harm than good. September 26, 2017. https://americanmigrainefoundation.org/resource-library/what-is-medication-overuse-headache/. (Accessed March 7, 2022).
- Garza I, Schwedt TJ. Medication overuse headache: treatment and prognosis. (Last updated July 13, 2021). In UpToDate, Post TW (ed), UpToDate, Waltham, MA 02013.
- Oskoui M, Pringsheim T, Billinghurst L, et al. Practice guideline update summary: pharmacologic treatment for pediatric migraine prevention: report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2019;93:500-9.
- Fischer MA, Jan A. Medication-overuse headache. StatPearls [Internet]. Last update July 19, 2021. https://www.ncbi.nlm.nih.gov/books/NBK538150/. (Accessed December 3, 2021).
- Becker WJ, Findlay T, Moga C, et al. Guideline for primary care management of headache in adults. Can Fam Physician2015;61:670-9.
Cite this document as follows: Clinical Resource, Medication Overuse Headache. Pharmacist’s Letter/Prescriber’s Letter. April 2022. [380403]